Sakiko Otani

Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor

Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +16

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara et al. · Clinical Lung Cancer · 2018 · 107 citations

Medicine, Immunology, Oncology +16

Circulating tumor cells as a prognostic factor in patients with small cell lung cancer

Satoshi Igawa, Keigo Gohda, Tomoya Fukui et al. · Oncology Letters · 2014 · 68 citations · Full text

Medicine, Oncology, Cancer Screening +16

Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance

Kenji Kita, Koji Fukuda, Hiro Takahashi et al. · Cancer Science · 2019 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +15

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

Satoshi Igawa, Yuichi Sato, Shinichiro Ryuge et al. · Oncology · 2017 · 38 citations

Medicine, Oncology, Pathology +17